Preventable-EU

Página Inicial
Portugal
Porto
Preventable-EU

Sustainable care for Rare Tumour Risk Syndromes

09/04/2026

✨ Gold Sponsor Spotlight

We are proud to highlight Grupo I.L.C and Element Biosciences as Gold Sponsors of the ###II Porto Cancer Meeting.

Their support plays a key role in advancing collaboration, innovation, and knowledge exchange in the field of hereditary cancer research and prevention.

Together, we are building a stronger scientific community and driving progress toward better outcomes for patients.

📍 Porto, Portugal
🗓 22–24 April 2026

08/04/2026

📅 Porto Cancer Meeting Agenda

Get ready for an inspiring programme at the ###II Porto Cancer Meeting: Bridging Research and Policy in Hereditary Cancer.

Over three days, the agenda will feature:
🔬 Cutting-edge research in hereditary cancer
🧬 Advances in genetics and prevention strategies
🤝 Discussions bridging science, policy, and patient care
🌍 Insights from leading international experts

Whether you are a researcher, clinician, or advocate, this is your opportunity to engage, learn, and collaborate.

📍 Porto, Portugal (i3S & SuperBock Arena – Pavilhão Rosa Mota)
🗓 22–24 April 2026

🔗 Explore the full agenda: https://www.i3s.up.pt/event.php?v=381

07/04/2026

🌍 World Health Day

Health is the foundation of strong communities and a better future for all. Today, we highlight the importance of prevention, early detection, and equitable access to healthcare.

From raising awareness about hereditary cancer risks to advancing research and innovation, every step toward better health matters.

💡 Investing in prevention today means healthier lives tomorrow.

Let us work together to build a world where everyone has the opportunity to live a healthier life.

06/04/2026

📢 Registration Open: 6th Course in Hereditary Cancer Genetics

Registration is open for the 6th Course in Hereditary Cancer Genetics (Bertinoro, 22–25 September 2026)!

This course offers a valuable opportunity to deepen your expertise in hereditary cancer genetics and connect with leading professionals in the field.

⚠️ Limited availability: only 85 on-site participants
🎓 Interested in a fellowship? The application deadline is 30 April. To guarantee your place regardless of the outcome, be sure to register early.

📣 Share with colleagues who may be interested!

🔗 More information & registration via ESHG European Society of Human Genetics: https://www.eshg.org/courses/hereditary-cancer-genetics-course

01/04/2026

🚀 Introducing the PREVENTABLE Learning Hub

A new space is coming to explore knowledge, tools, and insights on hereditary cancer risk, prevention, and care.

Designed to support researchers, healthcare professionals, and the wider community, the PREVENTABLE Learning Hub will bring together key resources to help turn knowledge into action.

Curious about what’s inside? 👀

Follow Us and Stay tuned!

🔎 Discover more about the project: https://preventable.eu/

29/03/2026

🎤 Speaker Spotlight: Zachariah F**a

We are pleased to welcome Zachariah F**a, Assistant Professor at Johns Hopkins University, as a speaker at the ###II Porto Cancer Meeting.

Dr. F**a specialises in cancer prevention and leads a clinic focused on individuals at high risk of colorectal cancer. His research explores cutting-edge approaches, such as liquid biopsies and cell-free DNA, to enable earlier detection and personalised prevention strategies.

📍 Porto, Portugal (i3S & SuperBock Arena – Pavilhão Rosa Mota)
🗓 22–24 April 2026

🔗 https://www.i3s.up.pt/event.php?v=381

28/03/2026

🎤 Speaker Spotlight: Tamara Hussong Milagre

We are honored to welcome Tamara Hussong Milagre, founder and president of EVITA Association, as a speaker at the ###II Porto Cancer Meeting.

A leading voice in hereditary cancer advocacy, Tamara has been empowering patients and shaping healthcare policy across Europe. Her work spans ERN GENTURIS, patient education, registries, and international collaborations in genomic medicine.

📍 Porto, Portugal (i3S & SuperBock Arena – Pavilhão Rosa Mota)
🗓 22–24 April 2026

🔗 https://www.i3s.up.pt/event.php?v=381

27/03/2026

🎤 Speaker Spotlight: Yasmina Okan

We are delighted to welcome Yasmina Okan, Senior Research Fellow at Universitat Pompeu Fabra, as a speaker at the ###II Porto Cancer Meeting.

An internationally recognised expert in health communication, Dr Okan focuses on how complex medical information, such as cancer risk, is understood by patients and the public, thereby supporting more informed and shared decision-making.

📍 Porto, Portugal (i3S & SuperBock Arena – Pavilhão Rosa Mota)
🗓 22–24 April 2026

🔗 https://www.i3s.up.pt/event.php?v=381

26/03/2026

🎤 Speaker Spotlight: Liora Bowers

We are pleased to welcome Liora Bowers, Policy Analyst at the OECD, as a speaker at the ###II Porto Cancer Meeting.

Liora works closely with the European Commission on the European Cancer Inequalities Registry and leads international benchmarking of cancer care quality indicators. Her expertise spans health system reform, financing, and tackling inequalities in cancer care.

📍 Porto, Portugal (i3S & SuperBock Arena – Pavilhão Rosa Mota)
🗓 22–24 April 2026

🔗 https://www.i3s.up.pt/event.php?v=381

25/03/2026

⏳ Final Days to Register – Porto Cancer Meeting

Time is running out! Don’t miss your chance to join the ###II Porto Cancer Meeting: Bridging Research and Policy in Hereditary Cancer.

Be part of an inspiring event bringing together leading experts, researchers, clinicians, and patient advocates to shape the future of cancer prevention and care.

📍 Porto, Portugal (i3S & SuperBock Arena – Pavilhão Rosa Mota)
🗓 22–24 April 2026

🚨 Last chance to secure your spot!
🔗 Register now: https://www.i3s.up.pt/event.php?v=381

24/03/2026

🎤 Speaker Spotlight: Enrique Terol

We are pleased to welcome Enrique Terol, Health Counsellor at the Permanent Representation of Spain to the EU, as a speaker at the ###II Porto Cancer Meeting.

With a distinguished career spanning clinical practice, healthcare management, and European health policy, Enrique Terol brings extensive expertise in public health and health system innovation. His work has been instrumental in shaping key strategies in areas such as rare diseases, patient safety, and chronic conditions.

At the European level, he has played a key role in the development and implementation of the European Reference Networks (ERNs)—a major step forward in improving care for patients with complex and rare diseases across Europe.

📍 Location: Porto, Portugal (i3S & SuperBock Arena – Pavilhão Rosa Mota)
🗓 Date: 22–24 April 2026

Join us at “Bridging Research and Policy in Hereditary Cancer”, a joint conference with the Preventable project, and gain insights at the intersection of science and policy.

🔗 Learn more about the event: https://www.i3s.up.pt/event.php?v=381

20/03/2026

📢 Reminder: Porto Cancer Meeting – Register Now!

The Porto Cancer Meeting is just around the corner, bringing together researchers, clinicians, and experts to explore the latest advances in cancer research, prevention, and care.

Don’t miss this opportunity to connect with the scientific community, exchange knowledge, and be part of the conversations shaping the future of oncology.

🗓 Secure your spot today and join us in Porto!
🔗 Register here: https://www.i3s.up.pt/event.php?v=381

Organizer:
i3S – Instituto de Investigação e Inovação em Saúde

Scientific Sponsors:
ERN GENTURIS
FLASH Project
ASPIC – Associação Portuguesa de Investigação em Cancro
Sociedade Portuguesa de Literacia em Saúde
Liga Portuguesa Contra o Cancro
Europacolon Portugal
Doenças Raras Portugal

Endereço

I3S – Institute For Research And Innovation In Health, University Of Porto Rua Alfredo Allen 208
Porto
4200-135

Website

https://preventable.eu/

Notificações

Seja o primeiro a receber as novidades e deixe-nos enviar-lhe um email quando Preventable-EU publica notícias e promoções. O seu endereço de email não será utilizado para qualquer outro propósito, e pode cancelar a subscrição a qualquer momento.